These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 2868992)

  • 1. Isolation of the outer membrane components of Bordetella pertussis which enhance the immunogenicity of Haemophilus influenzae type b capsular polysaccharide polyribosyl ribitol phosphate.
    Monji N; Stebbins MR; McCoy DW; Kuo JS
    Infect Immun; 1986 Mar; 51(3):865-71. PubMed ID: 2868992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety, tolerability, and immunogenicity of concurrent administration of Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate) with either measles-mumps-rubella vaccine or diphtheria-tetanus-pertussis and oral poliovirus vaccines in 14- to 23-month-old infants.
    Dashefsky B; Wald E; Guerra N; Byers C
    Pediatrics; 1990 Apr; 85(4 Pt 2):682-9. PubMed ID: 2107519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-polyribosyl-ribitol phosphate and anti-N. meningitidis outer membrane protein antibody levels following PRP-OMP conjugate vaccination.
    Wong VK; Kim KS
    Vaccine; 1993; 11(9):979-80. PubMed ID: 8212847
    [No Abstract]   [Full Text] [Related]  

  • 4. Antibody response of infants to Haemophilus influenzae type b capsular polysaccharide combined with Bordetella pertussis.
    Ambrosino DM; Glode MP; Williams CL; Siber GR
    J Infect Dis; 1985 Jun; 151(6):1174. PubMed ID: 2860187
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunogenicity of a Haemophilus influenzae polysaccharide-Neisseria meningitidis outer membrane protein complex conjugate vaccine.
    Donnelly JJ; Deck RR; Liu MA
    J Immunol; 1990 Nov; 145(9):3071-9. PubMed ID: 2120344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunogenicity of Haemophilus influenzae type b conjugate vaccines in infant rhesus monkeys.
    Vella PP; Ellis RW
    Pediatr Res; 1991 Jan; 29(1):10-3. PubMed ID: 2000253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An enzyme-linked immunosorbent assay for quantitation of Haemophilus Influenzae type b polysaccharide-specific IgG1 and IgG2 in human and infant rhesus monkey sera.
    Dolan KT; Staub JM; Schofield TL; Ahonkhai VI; Ellis RW; Vella PP
    J Immunoassay; 1991; 12(4):543-64. PubMed ID: 1806588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenicity of Haemophilus influenzae type b capsular polysaccharide vaccines in 18-month-old infants.
    Hendley JO; Wenzel JG; Ashe KM; Samuelson JS
    Pediatrics; 1987 Sep; 80(3):351-4. PubMed ID: 3306597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interchangeability of conjugated Haemophilus influenzae type b vaccines in infants.
    Anderson EL; Decker MD; Englund JA; Edwards KM; Anderson P; McInnes P; Belshe RB
    JAMA; 1995 Mar; 273(11):849-53. PubMed ID: 7869554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional activities of human antibody induced by the capsular polysaccharide or polysaccharide-conjugate vaccines against Haemophilus influenzae type b.
    Deveikis A; Ward J; Kim KS
    Vaccine; 1988 Feb; 6(1):14-8. PubMed ID: 3258459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccination of 18-month-old children with conjugated polyribosyl ribitol phosphate stimulates production of functional antibody to Haemophilus influenzae type b.
    Musher DM; Watson DA; Lepow ML; McVerry P; Hamill R; Baughn RE
    Pediatr Infect Dis J; 1988 Mar; 7(3):156-9. PubMed ID: 3258660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The acylated form of protein D of Haemophilus influenzae is more immunogenic than the nonacylated form and elicits an adjuvant effect when it is used as a carrier conjugated to polyribosyl ribitol phosphate.
    Akkoyunlu M; Melhus A; Capiau C; van Opstal O; Forsgren A
    Infect Immun; 1997 Dec; 65(12):5010-6. PubMed ID: 9393790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunogenicity of a Haemophilus influenzae type b vaccine in combination with diphtheria-pertussis-tetanus vaccine in infants.
    Coulehan JL; Hallowell C; Michaels RH; Welty TK; Lui N; Kuo JS
    J Infect Dis; 1983 Sep; 148(3):530-4. PubMed ID: 6311913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose-related immunogenicity of Haemophilus influenzae type b capsular polysaccharide-Neisseria meningitidis outer membrane protein conjugate vaccine.
    Wong VK; Quagliata R; Adler R; Kim KS
    Am J Dis Child; 1991 Jul; 145(7):742-5. PubMed ID: 2058604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disease caused by Haemophilus influenzae type b in the immediate period after homologous immunization: immunologic investigation.
    Sood SK; Daum RS
    Pediatrics; 1990 Apr; 85(4 Pt 2):698-704. PubMed ID: 2107522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate): immunogenicity and safety at various doses.
    Yogev R; Arditi M; Chadwick EG; Amer MD; Sroka PA
    Pediatrics; 1990 Apr; 85(4 Pt 2):690-3. PubMed ID: 2107520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody affinity in infants after immunization with conjugated capsular polysaccharide from Haemophilus influenzae type b.
    Hetherington SV; Rutkowski AF
    J Infect Dis; 1990 Nov; 162(5):1185-8. PubMed ID: 2230242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complement component 3 binding to Haemophilus influenzae type b in the presence of anticapsular and anti-outer membrane antibodies.
    Hetherington SV; Patrick CC
    Infect Immun; 1992 Jan; 60(1):19-24. PubMed ID: 1729183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation, antigenicity, and immunogenicity of synthetic ribosylribitol phosphate oligomer-protein conjugates and their potential use for vaccination against Haemophilus influenzae type b disease.
    Evenberg D; Hoogerhout P; van Boeckel CA; Rijkers GT; Beuvery EC; van Boom JH; Poolman JT
    J Infect Dis; 1992 Jun; 165 Suppl 1():S152-5. PubMed ID: 1588151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Avidity and bactericidal activity of antibody elicited by different Haemophilus influenzae type b conjugate vaccines. The Vaccine Study Group.
    Schlesinger Y; Granoff DM
    JAMA; 1992 Mar; 267(11):1489-94. PubMed ID: 1538539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.